News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
243 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17699)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (243)
2 (71)
4 (13)
5 (208)
6 (219)
7 (196)
8 (217)
9 (66)
11 (10)
12 (147)
13 (179)
14 (161)
15 (149)
16 (59)
18 (5)
19 (123)
20 (157)
21 (145)
22 (146)
23 (65)
24 (1)
25 (5)
26 (148)
27 (167)
28 (180)
29 (149)
30 (99)
31 (2)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
11
12
13
14
15
16
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Job Trends
Market Leader for Patient Identification and Tracking Software, EonDirect, Expands to Abdominal Aortic Aneurysm
By year’s end, Eon will expand its product portfolio to include a dozen new disease states that EonDirect will identify and track
August 1, 2019
·
3 min read
Business
Thrive Earlier Detection Announces Appointment of David J. Daly as Chief Executive Officer
Dave succeeds interim CEO, Steven J. Kafka, Ph.D., who will assume the role of executive chairman of the company’s board of directors.
August 1, 2019
·
3 min read
BioMidwest
Millendo Therapeutics to Participate in August Investor Conferences
Millendo Therapeutics is a late-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases where current therapies do not exist or are insufficient.
August 1, 2019
·
1 min read
Business
Merz Americas CEO Bob Rhatigan Joins Distinguished Life Sciences Leaders as a PharmaVOICE 100 Award Recipient
PharmaVOICE magazine announces most inspiring and influential leaders for its 2019 PharmaVOICE 100 awards
August 1, 2019
·
3 min read
Business
Javara and Tryon Medical Partners Working Together to Build a Robust Clinical Trials Offering
Javara and Tryon Medical Partners announced that they have formed a collaboration to offer industry-sponsored, outpatient clinical trials to Tryon Medical Partners’ patients.
August 1, 2019
·
2 min read
Business
Landrace Bioscience Acquires 40,000 Square Foot Processing Facility and 350,000 Pounds of Hemp for Pharmaceutical-Grade Consumer Products
In the newly acquired Tennessee processing facility, Landrace Bioscience will convert 350,000 pounds of hemp into a wide array of consumer products for wholesale use.
August 1, 2019
·
2 min read
Pharm Country
New NCCN Guidelines Are First to Address Small Intestine Cancers; Updates Highlight Developments in Genetic Testing and Hereditary Risk for Colon and Other Intestinal Cancers
New NCCN Guidelines for Small Bowel Adenocarcinoma are first clinical guidelines in the United States to address this rare but growing cancer type, which is sometimes associated with hereditary causes like Lynch syndrome
August 1, 2019
·
7 min read
Drug Development
Prokaryotics Receives $2.3 Million SBIR Award Supporting Its Immune Potentiation Program and Advances Two Additional SBIR-funded Antibiotic Programs into Phase 2 Lead Optimization
This 3-year fast track to Phase 2 award will fund an innovative therapeutic strategy developed by Prokaryotics aimed at hypersensitizing antimicrobial resistant Gram-negative bacterial pathogens to the host innate immune system.
August 1, 2019
·
2 min read
Morimoto Pharma Reveals New Exposure Prevention Prefilled Syringe Kits
Next Generation Injection Kit Designed by former Takeda Chief Researcher
August 1, 2019
·
2 min read
Business
MedicaSafe Appoints Esther Dyson and Dr. Andrew Saxon to Advisory Board
Medical and technology luminaries to work with drug-device combination technology company to improve management of high-risk medications
August 1, 2019
·
4 min read
Previous
12 of 25
Next